Insider Filing: Ming Jenny J Adds DERs; Ownership Totals Updated
Rhea-AI Filing Summary
Ming Jenny J, a director of Levi Strauss & Co. (LEVI), reported insider acquisitions on 08/08/2025 consisting of dividend equivalent rights (DERs) tied to the company's common stock. The filing shows the reporting person acquired 82 DERs that represent contingent rights to receive Class A common stock and 110 DERs that represent contingent rights to receive Class B common stock; the Class B DERs are noted as fully vested and subject to a deferral delivery feature. The report lists 64,442 shares of Class A common stock beneficially owned following the non-derivative transaction and 59,775 derivative securities beneficially owned following the reported derivative transaction. Each share of Class B common stock is convertible into one share of Class A common stock per the filing.
Positive
- Acquisition of 82 DERs representing contingent rights to receive Class A common stock
- Acquisition of 110 DERs representing contingent rights to receive Class B common stock (fully vested)
- Reported beneficial ownership of 64,442 Class A shares and 59,775 derivative securities following the transactions
Negative
- None.
Insights
TL;DR: Routine grant-based insider acquisitions increased a director's reported economic interest; transactions appear compensation-related and not valuation-changing.
The Form 4 documents acquisitions dated 08/08/2025 of equity-linked instruments (DERs) rather than open-market purchases. The reporting person acquired 82 DERs tied to Class A common stock and 110 DERs tied to Class B common stock, with the filing showing post-transaction beneficial ownership of 64,442 Class A shares and 59,775 derivative instruments. The Class B instruments are fully vested and the filing notes convertibility of Class B into Class A. From a market-impact perspective, these appear to be routine compensation or benefit awards rather than signaling a material change in control or a significant shift in ownership stake.
TL;DR: Award structure and vesting/deferral features align with typical director compensation; no governance red flags in the disclosed items.
The disclosure indicates derivative awards in the form of dividend equivalent rights that vest according to prescribed terms and, in the case of the Class B DERs, are fully vested but subject to a deferral delivery feature. The filing explicitly states conversion mechanics for Class B shares into Class A shares, which is normal for a dual-class structure. There is no disclosure in the form of unusual transfer restrictions, accelerated vesting tied to non-routine events, or disposals that would raise immediate governance concerns.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class B Common Stock | 110 | $0.00 | -- |
| Grant/Award | Class A Common Stock | 82 | $0.00 | -- |
Footnotes (1)
- Represents dividend equivalent rights (DERs), each of which represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The DERs shall vest as to 100% of the shares on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the date of grant of the underlying award. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. Represents DERs, each of which represents a contingent right to receive one share of the issuer's Class B Common Stock upon settlement. The DERs are fully vested. The underlying shares of Class B Common Stock issuable pursuant to the DERs are subject to a deferral delivery feature.